Nanobiotix News

Nanobiotix | 20-F: Registration statement / Annual report / Transition report

Apr 25 10:19

Nanobiotix | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 25 04:54

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 18 04:22

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 11 04:20

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Apr 3 04:19

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 7 05:21

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 14 05:22

Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(0%),Invus Public Equities Advisors, LLC(0%), etc.

Feb 10 06:12

Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qatar Investment Authority(9.1%)

Feb 9 09:31

Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Johnson & Johnson(11.9%),Johnson & Johnson Innovation-JJDC, Inc.(11.9%)

Feb 3 05:38

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Feb 1 05:19

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 30 05:19

Nanobiotix | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Baillie Gifford & Co (Scottish partnership)(6.21%)

Jan 29 23:58

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Jan 12 13:00

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 26, 2023 13:00

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 14, 2023 05:15

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 5, 2023 05:32

Nanobiotix | SC 13G: Statement of acquisition of beneficial ownership by individuals-Johnson & Johnson Innovation-JJDC, Inc.(10.2%),Johnson & Johnson(10.2%)

Nov 17, 2023 05:02

Nanobiotix | 6-K: Report of foreign private issuer (related to financial reporting)

Nov 14, 2023 05:15

Nanobiotix | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Nov 10, 2023 05:15